Division of Hematology

Research


The Bronx Blood Research Fund provides excellence in research and advances therapy and management of the thalassemias and the hemoglobinopathies.  

 

About

With combined resources from the Montefiore (Moses) and Einstein campuses, the Division of Hematology's history of excellence in scientific investigation includes funded research in embryonic stem cell investigations, high-throughput red blood cell engineering, chemically modified hemoglobins and albumin, in vitro red blood cell production, murine models of sickle cell disease, the role of nitric oxide and inflammation on microcirculation, plasma expanders, genetics, hemoglobin disorders, thrombosis, and hemostasis.

Research Investigators

Seetharama A. Acharya, Ph.D.  
Dr. Acharya has developed groundbreaking patents for work on hemoglobin and albumin modification as novel nitric oxide - producing resuscitation fluids with anti-inflammatory activity and an intrinsic ability to increase the efficacy of releasing oxygen from the red cell.

Ellen W. Friedman, MD 
Dr. Ellen Friedman’s passion is the study of the blood (hematology) and ensuring that the next generation of medical practioners are prepared to analyze and treat blood-related problems.

 

Henny Billett, M.D., M.Sc., FACP
Risk factors for thrombosis and microvascular disease, effect of race and ethnicity on thrombosis, thrombotic and microvascular complications of sickle cell disease.

John M. Greally, MB, BCh, PhD
Epigenetic regulation of gene expression.

 

Eric Bouhassira, Ph.D.
Hematopoietic (blood-forming) stem cells that can differentiate into red cells, T cells, platelets, and all other cell types that comprise blood.

Rhoda Hirsch, Ph.D.
Hemoglobinopathy HbE (β26 Glu →Lys) and its related diseases

 

Paul S. Frenette, MD
How hematopoietic stem cells (HSCs) and mature blood cells traffic in vivo.

Michael B. Stemerman, M.D.
LDL alters the function of the vascular endothelium and this alteration may be an important mechanism for the development of atherosclerosis.

 

Dr Irina Murakhovskaya's interests are in autoimmune disorders in hematology, hematologic problems associated with pregnancy, and plasma cell dyscrasias, such as MGUS and smoldering myeloma. She currently has clinical trials in autoimmune hemolytic anemia, cold agglutinin disease, PNH and atypical HUS. She is also a Hematology Course Director for Albert Einstein College of Medicine.

Dr. Swati Goel's research focuses on patients with blood disorders and blood-related cancers. Dr. Swati Goel specializes in the field of myeloproliferative disorders like myelofibrosis, polycythemia vera, and essential thrombocytosis. She is the leader of Myeloproliferative Disorder Clinical Trial Program at Montefiore Medical Center and Albert Einstein College of Medicine.She is actively recruiting patients in various clinical trials in these diseases for treatment. She is also a co-investigator in Hematology Biobank protocol which acts as the biorepository for various hematological disorders.

 

Spotlight

White Blood Cells Found to Play Key Role in Controlling Red Blood Cell Levels
A study led by Dr. Paul Frenette has revealed that macrophages also help to both produce and eliminate the body’s red blood cells.

 
 

Calendar



Full Calendar  

Contact Us

Division of Hematology
Albert Einstein College of Medicine

Jack and Pearl Resnick Campus
Ullmann Building, Room 403
1300 Morris Park Avenue
Bronx, NY 10461

718-430-2186

Click here to log in